Trinity Biotech TRIB
NASDAQ TRIB
$5.69 -0.63 (-9.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Trinity Biotech (TRIB) Liabilities from Discontinued Operations (2023 - 2024)

Updated

Trinity Biotech (TRIB) reported Liabilities from Discontinued Operations of -$800,000 for the quarter ended Dec 31, 2024, compared with $1.5 million a year earlier.

Analysis

Trinity Biotech (TRIB) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

  • By year, Liabilities from Discontinued Operations came in at $1.5 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn
10 Trinity Biotech 3.69 Mn 3.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -800,000.00
Dec 31, 2023 1.50 Mn
Mar 31, 2023 1.39 Mn
API Access

Trinity Biotech Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=TRIB&period=max&api_key=YOUR_API_KEY